Pharmacokinetics of a single oral dose of clobazam in patients with liver disease

Pharmacol Toxicol. 1994 Jun;74(6):345-50. doi: 10.1111/j.1600-0773.1994.tb01371.x.

Abstract

The pharmacokinetic effect of a single oral in dose of 20 mg clobazam was studied in 15 patients with liver disease and in 6 healthy volunteers. Plasma concentrations of clobazam and its main metabolite, norclobazam, were measured by gas liquid chromatography. Clobazam was rapidly absorbed. Peak plasma concentrations were 350 +/- 63 ng/ml at 1.7 +/- 0.8 hr in healthy volunteers, 239 +/- 70 ng/ml at 3 +/- 1.9 hr in patients with viral hepatitis and 240 +/- 113 ng/ml at 2.5 +/- 1.5 hr in patients with cirrhosis. Total distribution volume was 173 +/- 88 l and 168 +/- 71 l in patients with viral hepatitis and cirrhosis respectively, and 81 +/- 20 l in volunteers. Corresponding half-life values were 47 +/- 18 hr and 51 +/- 21 hr in patients and 22 +/- 6.3 hr in volunteers. The difference between patients was not significant, whereas the difference between patients and volunteers was significant.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Absorption
  • Administration, Oral
  • Adult
  • Aged
  • Anti-Anxiety Agents*
  • Anticonvulsants / administration & dosage
  • Anticonvulsants / pharmacokinetics*
  • Benzodiazepines*
  • Benzodiazepinones / administration & dosage
  • Benzodiazepinones / pharmacokinetics*
  • Chromatography, Gas
  • Clobazam
  • Female
  • Half-Life
  • Hepatitis, Viral, Human / metabolism*
  • Humans
  • Liver / metabolism
  • Liver Cirrhosis, Alcoholic / metabolism*
  • Male
  • Middle Aged

Substances

  • Anti-Anxiety Agents
  • Anticonvulsants
  • Benzodiazepinones
  • Benzodiazepines
  • Clobazam